InvestorsHub Logo
Followers 3
Posts 1781
Boards Moderated 0
Alias Born 07/06/2004

Re: None

Thursday, 05/07/2009 8:05:12 AM

Thursday, May 07, 2009 8:05:12 AM

Post# of 1467
Quarter Results out.... includes deficit of ($168,694,602.00 )

CC at 8.30 am....no guidance re: Dyloject or Ereska/FDA in PR.

They have listed JAV's NOLS...

Deficit accumulated during the development stage ($168,694,602.00)

...At this point I take it JAV is For Sale.